The principle of action of Letrozole involves its ability to inhibit the enzyme aromatase. Aromatase is responsible for converting androgens into estrogens, a process that occurs mainly in peripheral tissues such as adipose tissue and muscles. By inhibiting aromatase, Letrozole effectively reduces estrogen levels in the body. This mechanism is particularly important in the treatment of hormone receptor-positive breast cancer, where reduced estrogen levels help prevent the growth and spread of cancerous cells. Additionally, Letrozole is utilized in certain cases of female infertility by inducing ovulation through its impact on estrogen regulation. Overall, Letrozole plays a crucial role in hormonal therapies aimed at managing breast cancer and promoting fertility.
Letrozole is a medication that falls under the category of aromatase inhibitors. It is commonly prescribed to postmenopausal women with hormone receptor-positive breast cancer, where the tumor growth is influenced by estrogen production within the body.
The principle of action of Letrozole lies in its ability to reduce the production of estrogen by inhibiting the enzyme aromatase. Aromatase is responsible for converting androgens (male hormones) into estrogens (female hormones) through a process known as aromatization.
By blocking aromatase, Letrozole effectively decreases the levels of circulating estrogen in the body. This is crucial for breast cancer patients since estrogen can stimulate the growth of hormone receptor-positive tumors. By reducing estrogen levels, Letrozole helps stop the progression and spread of breast cancer cells.
Letrozole works by binding to the active site of the aromatase enzyme, thereby preventing it from carrying out the aromatization process. With reduced estrogen production, the tumor is deprived of the hormone required for its growth, leading to its regression or stabilization.
It’s important to note that Letrozole is only effective in postmenopausal women because their ovaries no longer produce significant amounts of estrogen. In Letrozole buy premenopausal women, the main source of estrogen is the ovaries, making aromatase inhibitors less effective as they do not target this source directly.
As a highly specific inhibitor, Letrozole does not interfere with other enzymes involved in steroid synthesis. This targeted approach minimizes potential side effects and allows for a more efficient reduction of estrogen levels.
Letrozole operates on the principle of inhibiting aromatase, an enzyme responsible for converting androgens into estrogens. By blocking this process, Letrozole effectively reduces estrogen production in postmenopausal women with hormone receptor-positive breast cancer. This inhibition helps prevent the growth and spread of cancer cells that rely on estrogen for their development. With its targeted action and minimal interference with other enzymes, Letrozole proves to be a valuable medication in the treatment of breast cancer.